Everise Honored as Leading Disability Employer 2024 by National Organization on Disability
PLANTATION,Fla.,Oct. 14,2024-- Global healthcare customer experience company Everise today announced that it has been recognized by the National Organization on Disability (NOD) as a Leading Disabili
Baseus Officially Launches in Over 1,400 U.S. Target Stores
NEW YORK,Oct. 14,2024--Baseus,a global leader in consumer electronics and accessories,proudly announces its debut in Target,one of the largest retail chains in the U.S. Starting this month,Baseus pro
Tsingke Shines at Cell & Gene Therapy International 2024
BEIJING and BOSTON,Oct. 14,2024-- BeijingTsingke Biotech Co.,Ltd. recently concluded a successful exhibition at CGTI2024 in Boston. This premier event attracted over 3,200 global attendees,including p
TOYO Co., Ltd Announces Plans for a 2 GW Solar Cell Manufacturing Facility in Ethiopia
TOKYO,Oct. 14,2024--TOYO Co.,Ltd (Nasdaq: TOYO) ("TOYO" or the "Company"),a solar solution company,is excited to announce its plan to establish a state-of-the-art solar cell manufa
With Indonesian Andika Rama coming in second in the Individual Championship,and Team Indonesia coming in first place in the Country Championship
East coast reigns supreme as the favourite in domestic tourism
BRISBANE,Australia,Oct. 15,2024-- Recent research fromBudget DirectTravel Insurance has revealed Australia\'s favourite destinations and habits when travelling domestically.
BEIJING,Oct. 15,2024--DBN Group,a leading high-tech agricultural enterprise,has opened its Phoenix International Innovation Park for global applications from high-quality agricultural biotech companie
Power grid construction is accelerating and enabling rapid economic development
KUITUN,China,Sept. 23,2024-- On September 22,the construction site of 220 kV power transmission and transformation project inKuitun East Industrial Park was busy with machinery roaring and vehicles sh
KOTA KINABALU,Malaysia,Sept. 21,2024-- European Wellness,a global leader in regenerative medicine and integrated healthcare,has inaugurated its latest and most advanced facility,the European Wellness
HANSIZHUANG (serplulimab) is the world\'s first anti-PD-1 mAb for first-line treatment of ES-SCLC - HANSIZHUANG (serplulimab) is expected to become the first and only anti-PD-1 monoclonal antibody ava